Mitochondria damage checkpoint, aging, and cancer
- PMID: 16803984
- DOI: 10.1196/annals.1354.022
Mitochondria damage checkpoint, aging, and cancer
Abstract
There is growing evidence supporting the progressing decline in mitochondrial function with age. Mitochondria are the major site of reactive oxygen species (ROS) production in the cell; therefore it is likely that progressive decline in mitochondrial function is due to the accumulation of oxidative damage with age. Despite this notion, a role for mitochondria in cellular senescence has been largely ignored. Our studies using mitochondrial gene knockout cells (rho(0)) from a variety of tissue types demonstrate that loss of mitochondrial function leads to cell cycle arrest, cellular senescence, and tumorigenic phenotype. In light of these and earlier studies we hypothesize the existence of a mitochondria damage checkpoint (mitocheckpoint) in human cells. Mitocheckpoint permits cells to arrest in the cell cycle in order to repair/restore mitochondrial function to the normal level. Upon overwhelming, persistent, or severe damage to mitochondria, mitocheckpoint machinery may allow cells to undergo senescence. Thus cellular senescence may function as another checkpoint before cells decide to initiate programmed cell death resulting in aging of tissues and organs. Alternatively, mutations occur in the mitochondrial and/or nuclear DNA, resulting in tumorigenesis.
Similar articles
-
Mitochondria damage checkpoint in apoptosis and genome stability.FEMS Yeast Res. 2004 Nov;5(2):127-32. doi: 10.1016/j.femsyr.2004.04.008. FEMS Yeast Res. 2004. PMID: 15489195 Review.
-
Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging.Exp Biol Med (Maywood). 2007 May;232(5):592-606. Exp Biol Med (Maywood). 2007. PMID: 17463155 Review.
-
Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.Chang Gung Med J. 2009 Mar-Apr;32(2):113-32. Chang Gung Med J. 2009. PMID: 19403001 Review.
-
Cancer, aging and cellular senescence.In Vivo. 2000 Jan-Feb;14(1):183-8. In Vivo. 2000. PMID: 10757076 Review.
-
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Mol Aspects Med. 2010. PMID: 20206201 Review.
Cited by
-
Radon-induced reduced apoptosis in human bronchial epithelial cells with knockdown of mitochondria DNA.J Toxicol Environ Health A. 2012;75(18):1111-9. doi: 10.1080/15287394.2012.699841. J Toxicol Environ Health A. 2012. PMID: 22891884 Free PMC article.
-
SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status.J Biol Chem. 2012 Apr 20;287(17):14078-86. doi: 10.1074/jbc.M112.355206. Epub 2012 Mar 13. J Biol Chem. 2012. PMID: 22416140 Free PMC article.
-
SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress.Cancer Cell. 2010 Jan 19;17(1):41-52. doi: 10.1016/j.ccr.2009.11.023. Cancer Cell. 2010. PMID: 20129246 Free PMC article.
-
Lifestyle and nutrition, caloric restriction, mitochondrial health and hormones: scientific interventions for anti-aging.Clin Interv Aging. 2007;2(4):537-43. doi: 10.2147/cia.s866. Clin Interv Aging. 2007. PMID: 18225453 Free PMC article. Review.
-
Hypothesis: Bifunctional mitochondrial proteins have centrosomal functions.Environ Mol Mutagen. 2009 Oct;50(8):637-48. doi: 10.1002/em.20508. Environ Mol Mutagen. 2009. PMID: 19565650 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
